LDS/Medical Tests/Chromosome Analysis, Sister Chromatid Exchange (SCE) for Bloom Syndrome, Blood

Chromosome Analysis, Sister Chromatid Exchange (SCE) for Bloom Syndrome, Blood

Bloom syndrome is a rare autosomal recessive genomic instability disorder caused by loss-of-function pathogenic variants in the BLM gene, which encodes a RecQ family DNA helicase essential for DNA replication, repair, and maintenance of genomic integrity. Affected individuals typically present with severe prenatal and postnatal growth deficiency, photosensitive skin changes, immunodeficiency, insulin resistance, and a markedly increased lifetime risk of early-onset and multiple malignancies. At the cellular level, defective BLM function leads to excessive homologous recombination, resulting in pronounced chromosomal instability.

One of the defining cytogenetic features of Bloom syndrome is a dramatically elevated rate of sister chromatid exchanges (SCEs), which are reciprocal exchanges of DNA between sister chromatids during mitosis. This finding is considered specific for Bloom syndrome and distinguishes it from other inherited chromosome instability syndromes. The SCE assay is therefore a cornerstone diagnostic test for Bloom syndrome.

The assay is performed on cultured peripheral blood lymphocytes. Cells are incubated with a thymidine analog such as bromodeoxyuridine (BrdU) to allow differential labeling of sister chromatids over two cell cycles. After metaphase arrest and differential staining, sister chromatid exchanges are visualized and quantified by microscopy. In healthy individuals, SCEs occur at a low baseline frequency, whereas cells from individuals with Bloom syndrome exhibit extremely high numbers of exchanges per metaphase, reflecting profound defects in DNA repair and replication fidelity. Although molecular testing of the BLM gene can confirm the diagnosis, the SCE assay remains a rapid and reliable functional test, particularly in cases where genetic testing is inconclusive or unavailable.

  • Confirmatory diagnostic test for Bloom syndrome in patients with characteristic clinical features
  • Differentiates Bloom syndrome from other genomic instability syndromes such as Fanconi anemia or ataxia-telangiectasia
  • Provides critical information for genetic counseling regarding autosomal recessive inheritance, recurrence risk, and reproductive options
Markedly increased sister chromatid exchange frequency (>50) is consistent with Bloom syndrome when correlated with clinical findings and family history. Mild or borderline elevations are not diagnostic and should prompt consideration of alternative diagnoses or technical factors. Normal SCE frequency effectively excludes Bloom syndrome.

Normal: 5-10 exchanges per metaphase Bloom syndrome: >50 exchanges per metaphase

Sister chromatid exchange (SCE) analysis using cultured peripheral blood lymphocytes and differential chromatid staining.

Whole blood collected in heparin (green-top) vial.

Stability

  • Ambient: 1-3 days
  • Refrigerated: avoid
  • Frozen: unacceptable
BLM gene sequencing or deletion/duplication analysis, conventional cytogenetic karyotyping if indicated.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login